IL162295A0 - Tetracyclic heterocompounds as estrogen receptor modulators - Google Patents
Tetracyclic heterocompounds as estrogen receptor modulatorsInfo
- Publication number
- IL162295A0 IL162295A0 IL16229502A IL16229502A IL162295A0 IL 162295 A0 IL162295 A0 IL 162295A0 IL 16229502 A IL16229502 A IL 16229502A IL 16229502 A IL16229502 A IL 16229502A IL 162295 A0 IL162295 A0 IL 162295A0
- Authority
- IL
- Israel
- Prior art keywords
- heterocompounds
- tetracyclic
- estrogen receptor
- receptor modulators
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34195701P | 2001-12-19 | 2001-12-19 | |
| PCT/US2002/038486 WO2003053977A1 (en) | 2001-12-19 | 2002-12-02 | Tetracyclic heterocompounds as estrogen receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162295A0 true IL162295A0 (en) | 2005-11-20 |
Family
ID=23339719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16229502A IL162295A0 (en) | 2001-12-19 | 2002-12-02 | Tetracyclic heterocompounds as estrogen receptor modulators |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1467998B1 (xx) |
| JP (1) | JP2005513133A (xx) |
| CN (1) | CN1620457A (xx) |
| AR (1) | AR038661A1 (xx) |
| AT (1) | ATE321764T1 (xx) |
| AU (1) | AU2002362041A1 (xx) |
| BR (1) | BR0215152A (xx) |
| CA (1) | CA2471107A1 (xx) |
| CY (1) | CY1105361T1 (xx) |
| DE (1) | DE60210333T2 (xx) |
| DK (1) | DK1467998T3 (xx) |
| ES (1) | ES2264737T3 (xx) |
| HK (1) | HK1068875A1 (xx) |
| HU (1) | HUP0500103A3 (xx) |
| IL (1) | IL162295A0 (xx) |
| MX (1) | MXPA04006034A (xx) |
| NZ (1) | NZ533281A (xx) |
| PL (1) | PL371045A1 (xx) |
| PT (1) | PT1467998E (xx) |
| RU (1) | RU2305099C2 (xx) |
| WO (1) | WO2003053977A1 (xx) |
| ZA (1) | ZA200405653B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105679B2 (en) | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US7329654B2 (en) * | 2001-12-19 | 2008-02-12 | Janssen Pharmaceutica N.V. | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| WO2005073244A1 (en) * | 2004-01-22 | 2005-08-11 | Eli Lilly And Company | Selective estrogen receptor modulators |
| SI1796664T1 (sl) | 2004-09-20 | 2014-02-28 | Janssen Pharmaceutica N.V. | Novi tetraciklični derivati, ki vsebujejo heteroatome, in so uporabni kot modulatorji receptorja spolnega steoidnega hormona |
| AU2006259352A1 (en) | 2005-06-15 | 2006-12-28 | Fibrogen, Inc. | Use of HIF 1alfa modulators for treatment of cancer |
| DE102006024032A1 (de) * | 2006-05-23 | 2007-11-29 | Voith Patent Gmbh | Anordnung zur Bandregelung |
| KR101698238B1 (ko) * | 2010-06-10 | 2017-01-19 | 세라곤 파마슈티컬스, 인크. | 에스트로겐 수용체 조정제 및 이의 용도 |
| SG11201403002RA (en) * | 2011-12-14 | 2014-07-30 | Seragon Pharmaceuticals Inc | Fluorinated estrogen receptor modulators and uses thereof |
| CN113135884B (zh) * | 2020-01-20 | 2023-03-10 | 西华大学 | 一种异色烯类化合物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL124481C (xx) * | 1964-11-04 | |||
| CA2214196A1 (en) * | 1996-09-26 | 1998-03-26 | Eli Lilly And Company | Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| EP0944613B1 (en) * | 1996-12-13 | 2002-10-09 | Chugai Seiyaku Kabushiki Kaisha | Benzopyran derivatives |
-
2002
- 2002-12-02 RU RU2004118606/04A patent/RU2305099C2/ru not_active IP Right Cessation
- 2002-12-02 DE DE60210333T patent/DE60210333T2/de not_active Expired - Fee Related
- 2002-12-02 JP JP2003554693A patent/JP2005513133A/ja not_active Withdrawn
- 2002-12-02 IL IL16229502A patent/IL162295A0/xx unknown
- 2002-12-02 ES ES02797167T patent/ES2264737T3/es not_active Expired - Lifetime
- 2002-12-02 PL PL02371045A patent/PL371045A1/xx not_active Application Discontinuation
- 2002-12-02 PT PT02797167T patent/PT1467998E/pt unknown
- 2002-12-02 BR BR0215152-9A patent/BR0215152A/pt not_active IP Right Cessation
- 2002-12-02 AT AT02797167T patent/ATE321764T1/de not_active IP Right Cessation
- 2002-12-02 DK DK02797167T patent/DK1467998T3/da active
- 2002-12-02 EP EP02797167A patent/EP1467998B1/en not_active Expired - Lifetime
- 2002-12-02 NZ NZ533281A patent/NZ533281A/en unknown
- 2002-12-02 WO PCT/US2002/038486 patent/WO2003053977A1/en active IP Right Grant
- 2002-12-02 CN CNA028281446A patent/CN1620457A/zh active Pending
- 2002-12-02 CA CA002471107A patent/CA2471107A1/en not_active Abandoned
- 2002-12-02 AU AU2002362041A patent/AU2002362041A1/en not_active Abandoned
- 2002-12-02 MX MXPA04006034A patent/MXPA04006034A/es active IP Right Grant
- 2002-12-02 HU HU0500103A patent/HUP0500103A3/hu unknown
- 2002-12-18 AR ARP020104957A patent/AR038661A1/es unknown
-
2004
- 2004-07-15 ZA ZA200405653A patent/ZA200405653B/xx unknown
-
2005
- 2005-02-15 HK HK05101213A patent/HK1068875A1/xx not_active IP Right Cessation
-
2006
- 2006-06-08 CY CY20061100768T patent/CY1105361T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1068875A1 (en) | 2005-05-06 |
| ZA200405653B (en) | 2006-06-28 |
| ATE321764T1 (de) | 2006-04-15 |
| CA2471107A1 (en) | 2003-07-03 |
| AU2002362041A1 (en) | 2003-07-09 |
| EP1467998A1 (en) | 2004-10-20 |
| PT1467998E (pt) | 2006-08-31 |
| PL371045A1 (en) | 2005-06-13 |
| DK1467998T3 (da) | 2006-07-31 |
| AR038661A1 (es) | 2005-01-26 |
| RU2004118606A (ru) | 2006-01-10 |
| EP1467998B1 (en) | 2006-03-29 |
| DE60210333D1 (de) | 2006-05-18 |
| HUP0500103A2 (hu) | 2005-05-30 |
| DE60210333T2 (de) | 2006-11-30 |
| MXPA04006034A (es) | 2005-03-31 |
| JP2005513133A (ja) | 2005-05-12 |
| WO2003053977A1 (en) | 2003-07-03 |
| ES2264737T3 (es) | 2007-01-16 |
| RU2305099C2 (ru) | 2007-08-27 |
| NZ533281A (en) | 2007-05-31 |
| BR0215152A (pt) | 2004-10-19 |
| CY1105361T1 (el) | 2010-03-03 |
| HUP0500103A3 (en) | 2009-01-28 |
| CN1620457A (zh) | 2005-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL374215A1 (en) | Selective estrogen receptor modulators | |
| HK1068875A1 (en) | Tetracyclic heterocompounds as estrogen receptor modulators | |
| EP1418900A4 (en) | SELECTIVE ESTROGEN RECEPTOR MODULATORS | |
| EG25606A (en) | Glucocorticoid receptor modulators | |
| IL150912A0 (en) | Adenosine receptor modulators | |
| AU2002236114A1 (en) | Tricyclic androgen receptor modulator compounds | |
| PL376803A1 (pl) | Nowe pochodne tetracykliczne zawierające heteroatomy, jako selektywne modulatory receptora estrogenowego | |
| IL154984A0 (en) | Estrogen receptor modulators | |
| AU2002335075A1 (en) | Estrogen receptor modulators | |
| AU2003231523A1 (en) | Estrogen receptor modulators | |
| EP1434786A4 (en) | ANDROSTAN-17-BETA-CARBOXAMIDE AS MODULATORS OF THE ANDROGEN RECEPTOR | |
| EP1467739A4 (en) | 17-HYDROXY-4-AZA-ANDROSTAN-3-ONE AS ANDROGEN RECEPTOR MODULATORS | |
| SI1467998T1 (sl) | Tetraciklicne heterospojine kot modulatorji estrogenskega receptorja | |
| SG114650A1 (en) | Cyclocarbamate derivatives as progesterone receptor modulators | |
| PL370980A1 (en) | Benzothiophenes as adenosine receptor modulators | |
| AU2002249971A1 (en) | Piperazinyltriazines as estrogen receptor modulators | |
| AU2002252533A1 (en) | Estrogen receptor modulators | |
| GB0100298D0 (en) | Estrogen receptor | |
| GB0100299D0 (en) | Estrogen receptor | |
| GB0100301D0 (en) | Estrogen receptor | |
| GB0100302D0 (en) | Estrogen receptors | |
| AU2002255847A1 (en) | Aminopyridine derivatives as estrogen receptor modulators | |
| GB0125183D0 (en) | Receptor | |
| GB0110662D0 (en) | Receptor | |
| GB0111959D0 (en) | Receptor |